Abstract:The effectiveness of oral, mock-, and immersion vaccination was investigated against white spot syndrome virus (WSSV) in crayfish. The most exposed WSSV envelope proteins VP19 and VP28 were used in different compositions and with different modes of applications. In experiment 1 crayfish were fed recombinant protein coated food pellets for 25 days, in experiment 2 the purified proteins were directly injected to them followed by one booster dose on 5th day and in experiment 3 the crayfish were left immersed in vaccines for 7h. Experimental crayfish were challenged on 3rd and 21st days after last vaccination. The overall result showed that VP28 group has lowest cumulative mortality percentage accounting 39.6% at 3rd day and 39.83% at 21st day when injected and it was 43.2% and 49% when fed orally and 46.3% and 46.5% when immersed at 3rd and 21st days, respectively (p<0.05). In VP19 and VP28 (50:50) mixture, mock vaccination showed better performance (36.5%) over immersion (53%) and oral vaccination (53.2%) when challenged on 3rd day and mock vaccination (36.50%) followed by oral (51%) and immersion vaccination (56.5%) on 21st day as well. The VP19 recombinant mock vaccination group performed better (52.91% of 3rd day and 56.46% of 21st day) than oral (76% of 3rd day and 82% of 21st day) and immersion (83% of 3rd day and 86.3% of 21st day) vaccine groups. All the experimental groups except VP19 were significantly different (p<0.05) from the control groups. A positive cumulative effect was observed when VP28 was mixed with VP19 in equal proportion in all the experimental trials, which shows the effectiveness of VP19 as a vaccine component too. In the present trial on the basis of cumulative mortality percentage it is found that mock-vaccination group is more effective than the oral vaccination and immersion vaccination. It also suggests that specific memory exists in crayfish and the effects of VP28 are significant. The effect of VP19 along with VP28 has also shown significant effect against WSSV.

Protection of Procambarus Clarkii Against White Spot Syndrome Virus Using Recombinant Subunit Injection Vaccine Expressed in Pichia Pastoris

The Efficacy of Recombinant Vaccines Against White Spot Syndrome Virus in Procambarus Clarkii.

Oral Vaccination Trials with Crayfish, Procambarus Clarkii, to Induce Resistance to the White Spot Syndrome Virus

Oral Vaccination with Envelope Protein VP28 Against White Spot Syndrome Virus in Procambarus Clarkii Using Bacillus Subtilis As Delivery Vehicles.

Increased resistance to white spot syndrome virus in Procambarus clarkii by injection of envelope protein VP28 expressed using recombinant baculovirus

A Vector That Expresses VP28 of WSSV Can Protect Red Swamp Crayfish from White Spot Disease.

EFFECT OF WHITE SPOT SYNDROME VIRUS ENVELOPE PROTEIN Vp28 EXPRESSED IN SILKWORM (BOMBYX MORI) PUPAE ON DISEASE RESISTENCE IN PROCAMBARUS CLARKII

Protection of crayfish, Cambarus clarkii, from white spot syndrome virus by polyclonal antibodies against a viral envelope fusion protein.

Dietary Chitosan Nanoparticles Protect Crayfish Procambarus Clarkii Against White Spot Syndrome Virus (wssv) Infection

TAT-mediated oral subunit vaccine against white spot syndrome virus in crayfish.

Crayfish Procambarus Clarkii Protected Against White Spot Syndrome Virus by Oral Administration of Viral Proteins Expressed in Silkworms

Surface-displayed VP28 on Bacillus subtilis spores induce protection against white spot syndrome virus in crayfish by oral administration.

Oral Delivery of DNA Vaccine Encoding VP28 Against White Spot Syndrome Virus in Crayfish by Attenuated Salmonella Typhimurium

Passive Immunization of Crayfish ( Procambius clarkiaii ) with Chicken Egg Yolk Immunoglobulin (IgY) Against White Spot Syndrome Virus (WSSV)

Expression of Envelope Protein VP19 of Penaeus monodon WSSV in E.coli and the Effect against WSSV

Antigenic and Immunogenic Properties of Truncated VP28 Protein of White Spot Syndrome Virus in Procambarus Clarkii

Expression of Envelope Protein VP28 of Penaeus monodon WSSV in E. coli and the Effect Against WSSV

Effects of Oral Recombinant VP28 Expressed in Silkworm ( Bombyx Mori ) Pupa on Immune Response and Disease Resistance of Procambarus Clarkii

Effect of VP28 DNA Vaccine on White Spot Syndrome Virus in Litopenaeus Vannamei

Advance in WSSV Subunit Vaccine

Immune responses of Fenneropenaeus chinensis against white spot syndrome virus after oral delivery of VP28 using Bacillus subtilis as vehicles.